Literature DB >> 200967

Stimulus effects of delta(9)-THC and its interaction with naltrexone and catecholamine blockers in rats.

T U Järbe, G C Ohlin.   

Abstract

Rats trained in a T-shaped maze to discriminate the effects of i.p. injections of delta(9)-tetrahydrocannabinol (delta(9)-THC, 4 mg/kg) and the effects of the vehicle were tested for antagonism and generalization to the delta(9)-THC stimulus by naltrexone (4 mg/kg), haloperidol (0.32 mg/kg), propranolol (20 mg/kg), and phenoxybenzamine (10 mg/kg). None of these drugs blocked the delta(9)-THC stimulus, nor were they found to generalize to delta(9)-THC.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200967     DOI: 10.1007/bf00426779

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol.

Authors:  B Hine; E Friedman; M Torrelio; S Gershon
Journal:  Science       Date:  1975-02-07       Impact factor: 47.728

2.  Fentanyl and apomorphine: asymmetrical generalization of discriminative stimulus properties.

Authors:  F C Colpaert; C J Niemegeers; P A Janssen
Journal:  Neuropharmacology       Date:  1976-09       Impact factor: 5.250

3.  Selective interaction of drugs with a discriminable stimulus associated with narcotic action.

Authors:  G Gianutsos; H Lal
Journal:  Life Sci       Date:  1976-07-01       Impact factor: 5.037

4.  Dopaminergic mediation of the interoceptive cue produced by d-amphetamine in rats.

Authors:  M D Schechter; P G Cook
Journal:  Psychopharmacologia       Date:  1975-05-28

5.  Evaluation of the discriminative effects of morphine in the rat.

Authors:  H E Shannon; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1976-07       Impact factor: 4.030

6.  Morphine as a discriminative cue: effects of amine depletors and naloxone.

Authors:  J A Rosecrans; M H Goodloe; G J Bennett; I D Hirschhorn
Journal:  Eur J Pharmacol       Date:  1973-02       Impact factor: 4.432

7.  Antagonism of morphine by long acting narcotic antagonists.

Authors:  L A Dykstra; D E McMillan; L S Harris
Journal:  Psychopharmacologia       Date:  1974

8.  Stimulus properties of the narcotic antagonist pentazocine: similarity to morphine and antagonism by naloxone.

Authors:  D M Kuhn; I Greenberg; J B Appel
Journal:  J Pharmacol Exp Ther       Date:  1976-01       Impact factor: 4.030

9.  Similarities between delta9-tetrahydrocannabinol (delta9-THC) and reserpine-like drugs.

Authors:  B Carder; S M Deikel
Journal:  Behav Biol       Date:  1976-07

10.  Characteristics of tetrahydrocannabinol (THC)-produced discrimination in rats.

Authors:  T U Järbe; J O Johansson; B G Henriksson
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

View more
  5 in total

1.  Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.

Authors:  Marcello Solinas; Steven R Goldberg
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

Review 2.  [Future medications for tobacco and cannabis dependence].

Authors:  Bernard Le Foll; Zuzana Justinova; Gianlugi Tanda; Steven R Goldberg
Journal:  Bull Acad Natl Med       Date:  2008-01       Impact factor: 0.144

Review 3.  Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?

Authors:  Patrycja Kleczkowska; Irena Smaga; Małgorzata Filip; Magdalena Bujalska-Zadrozny
Journal:  Neurotox Res       Date:  2016-08-02       Impact factor: 3.911

4.  Generalization of the discriminative stimulus properties of delta 9-THC to delta 9(11)-THC in rats.

Authors:  A Semjonow; M Binder
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

5.  S(-)Propranolol as a discriminative stimulus and its comparison to the stimulus effects of cocaine in rats.

Authors:  Richard Young; Richard A Glennon
Journal:  Psychopharmacology (Berl)       Date:  2008-09-16       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.